Investment
Features
FeesSafety
Academy
More
Pluang+

Compare TransMedics Group Inc (TMDX) vs Unity Software Inc (U) Price & Performance

TransMedics Group IncTrade
Unity Software IncTrade

Price performance (Past 24H)

Key statistics

TransMedics Group Inc vs Unity Software Inc — how do they compare? TransMedics Group Inc trades at $80.68 (market cap $2.74B), while Unity Software Inc trades at $46.69 (market cap $20.20B). The key difference: Unity Software Inc is far larger — about 7.4× TransMedics Group Inc's market cap, and Unity Software Inc is trading nearer its 52-week high, TransMedics Group Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold TransMedics Group Inc for 24 Days and Unity Software Inc for 50 Days on average.

TMDXU
Market Cap
$2.74B$20.20B
Volume
949,33115,432,191
Sector
HealthTechnology
52-Week High
$150.42$49.47
52-Week Low
$61.99$17.13
Typical Hold Time
24 Days50 Days
Enterprise Value
$3.13B$20.08B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

TransMedics Group Inc

TransMedics Group (TMDX) trades at $80.69, down 0.47% on the day, amid a bearish technical signal and mixed earnings performance. The company reported strong revenue growth to $605.49M in 2025 with a net income margin of 22.69%, but recent quarters have seen earnings misses. Analyst sentiment remains positive with a consensus price target of $99.75 and a 69% buy rating, though news flow includes investigations into fiduciary duties.

The outlook balances robust fundamentals against near-term headwinds. Upside potential exists from the high analyst target and strong profitability metrics like a 36.28% ROE, but risks include earnings volatility, margin pressure, and ongoing legal scrutiny. The stock's current valuation at a P/E of 20.47 offers a reasonable entry if execution improves.

Unity Software Inc

Unity Software (U) trades at $45.44, up 1.09% on the day, with a bullish technical signal and strong analyst support. The stock is near its pivot point of $45, with immediate resistance at $46. Fundamentally, revenue reached $1.85B in 2025, but the company reported a net loss of -$402.77M, though losses are narrowing year-over-year. Recent news highlights momentum from Meta VR Glasses support and positive sector sentiment.

Outlook: Strong buy consensus (82% of analysts) and a $46.54 price target suggest upside, but persistent losses and high valuation ratios pose risks. Investment appeal hinges on revenue growth and path to profitability, while competitive and execution risks remain key concerns for investors.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

TMDX
100% Buy0% Sell
Avg holding period · 24 Days
U

No sentiment data available yet.

Top news

Latest headlines on both assets

About TransMedics Group Inc

TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.

Read more on TMDX →

About Unity Software Inc

Unity Software Inc provides a software platform for creating and operating interactive, real-time 3D content. The platform can be used to create, run and monetize interactive, real-time 2D and 3D content for mobile phones, tablets, PCs, consoles, and augmented and virtual reality devices. The business is spread across the United States, Greater China, EMEA, APAC and Other Americas, of which key revenue is derived from the EMEA region. The products are used in the gaming industry, architecture and construction sector, animation industry, and designing sector.

Read more on U →